期刊文献+

1998,2001和2004年绵阳市慢性心力衰竭住院患者药物治疗动态分析 被引量:19

下载PDF
导出
摘要 目的了解绵阳市慢性心力衰竭患者药物治疗动态,分析用药合理性。方法采用绵阳市3所医院1998,2001和2004年住院慢性心力衰竭患者病历数据库,对慢性心力衰竭患者使用药物治疗状况进行调查分析。结果绵阳市3家医院3年慢性心力衰竭患者共1882例。1998年,2001年和2004年药物使用率分别是:利尿剂63.7%→68.1%→74.5%、洋地黄类40.2%→42.4%→67.9%、ACEI/ARB(血管紧张素转换酶抑制剂/血管紧张素受体拮抗剂)18.2%→30.3%→59.2%、β-blocker(β受体阻滞剂)14.9%→31.2%→60.1%、硝酸盐类42.5%→48.2%→56.3%、非洋地黄类正性肌力药物25.7%→28.9%→20.7%、钙离子拮抗剂17.5%→18.3%→20.1%。不使用β-blocker的主要原因是窦性心动过缓。不使用ACEI/ARB的主要原因是低血压。未考虑使用β-blocker占不用原因的32.6%,未考虑使用ACEI/ARB占不用原因的34.6%。结论提示自心力衰竭治疗指南公布以来,绵阳市心力衰竭患者规范化药物治疗水平有了明显提高。
出处 《四川医学》 CAS 2006年第6期598-600,共3页 Sichuan Medical Journal
  • 相关文献

参考文献9

  • 1Remme WJ, Swedberg K.Guidelines for the diagnosis and treatment of chronic heart failure : Task force for the diagnosis and treatment of chronic heart failure[J]. Eur Heart J,2001,22( 17):1527- 1560
  • 2Hunt HA, Baker DW,Chin MH, et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure[J]. Circulation, 2001,104(24) : 2996 - 3007
  • 3慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量:2413
  • 4程康安,吴宁.中国部分地区1980、1990、2000年慢性心力衰竭住院病例回顾性调查[J].中华心血管病杂志,2002,30(8):450-454. 被引量:359
  • 5Glick H,Cook J, Kinosian B, et al. Costs and effects of enalapril therapy in patients with symptomatic heart failure:an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD)Treatment Trial[J] .J Card Fail,1995,1(5):371 - 380
  • 6CONSENSUS trial study group, Effect of enalapril on mortality in severe congestive heart failure:result of the north scandinavian enalapril survival study(CONSENSUS ) [ J ]. N Engl J Med, 1987,316( 23 ) : 1429 - 1435
  • 7CIBIS Ⅱ investigators and committees. The cardiac insufficiency bisoprolol study (CIBIS Ⅱ) :a randomized trial[J]. Lancet, 1999,353(9146):9 - 13
  • 8MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) [J]. Lancet, 1999,353 (9169) : 2001 - 2007
  • 9Fowler MB. Carvedilol prospective randomized cumulative survival(COPERNICUS)Trial: carvedilol in severe heart Failure [J] .Am J Cardiol,2004,93(9A) :35B - 39B

二级参考文献8

  • 1Kalon KL,Joan LP, William BK. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol, 1993,22 (Suppl A):6A-13A.
  • 2Hung YT, Cheug NT, Ip S. Epidemiology of heart failure in Hong Kong,1997. Hong Kong Med J, 2000,6:159-162.
  • 3Packer M, Coats AJS, Fowler MB, et al. For the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effects of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001, 344:1651-1658.
  • 4Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J, 2001, 22: 1527-1561.
  • 5Hunt HA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the international society for heart and lung transplantation. Circulation, 2001, 104:2996-3007.
  • 6Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999
  • 7上海市心力衰竭调查协作组,范维琥,张平宽,李勇.上海市稳定性心力衰竭患者药物治疗现状调查[J].中华心血管病杂志,2001,29(11):644-648. 被引量:37
  • 8慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量:2413

共引文献2731

同被引文献171

引证文献19

二级引证文献241

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部